In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...

The major U.S. equity indexes were lower midday Monday, as the Trump administration showed no signs of pulling back from ...

US indices retreat on tariff worries as VIX jumps to 22.44. Nvidia drops 3.9%, Microsoft falls 2.2%, while defensive sectors provide limited market support.

In this article, we are going to look at where Moderna, Inc. (NASDAQ ... and a supportive regulatory environment, Goldman Sachs referred to it as an “undervalued opportunity.” ...

S&P 500 and Nasdaq had their worst quarters since 2022 due to concerns over Trump's economic policy and new tariffs. The S&P 500 dropped 4.6% and Nasdaq fell 10.5%. Tech stocks like Tesla and Nvidia ...

The S&P 500 and the Nasdaq Composite today posted their worst quarterly performances since 2022, as uncertainty around the Trump administration’s economic agenda roiled U.S. equity markets in the ...

US stocks tumbled to their lowest levels in over six months as worries over new tariffs weighed on investor sentiment. With fears of a global slowdown and rising inflation, the S&P 500 and Nasdaq saw ...